Cervical cancer poses a significant global health challenge, necessitating advanced treatment strategies to improve patient outcomes. Radiotherapy, a cornerstone of cervical cancer treatment, aims to target tumors while minimizing exposure to organs at risk (OARs). Mixed beam planning (MBP), which combines various radiation beams, has emerged as a promising approach to achieve this delicate balance. This study delves into the dosimetric impact of MBP on absorbed doses in tumors and OARs for cervical cancer patients, utilizing a comprehensive dosimetric analysis approach.
In low- and middle-income countries, cervical cancer remains a major health concern. Radiation therapy plays a vital role in the treatment landscape, employing diverse techniques to enhance tumor control and reduce damage to adjacent healthy tissues known as OARs. The research investigates the dosimetric effects of absorbed doses in tumors and OARs, specifically examining the integration of photon beams (6 MV & 15 MV) in MBP for cervical cancer treatment.
The study included twenty cervical cancer patients who had previously undergone conventional photon radiotherapy planning. Imaging and staging using CT simulation were conducted to accurately delineate tumors and OARs such as the bladder, rectum, femoral head, and small bowel. Three treatment plans were generated for each patient: conventional 6 MV photon beam, conventional 15 MV photon beam, and mixed 6 MV + 15 MV beam energies, aiming to deliver 50.0 Gy to the target planned volume over 25 fractions using the Monaco treatment planning system.
Dosimetric parameters including mean dose, maximum dose, and dose-volume histograms (DVHs) were analyzed for tumors and OARs. Primary endpoints focused on the dose delivered to the planning target volume (PTV) and the sparing of OARs such as the bladder, rectum, femoral head, and bowel bag. Comparisons were made between mixed beam and photon-only plans, evaluating key parameters like D95, Dmean, and V45 to assess dosimetric efficacy.
The Monaco treatment planning system played a crucial role in creating and optimizing radiotherapy plans for cervical cancer patients, particularly in incorporating mixed beam energy approaches. By utilizing Monte Carlo algorithms for precise dose calculations, the system optimized mixed-energy beam planning effectively. The study showcased that mixed beam planning provided superior tumor coverage compared to single modality plans, with enhanced dose distribution within the tumor and reduced exposure to OARs.
Furthermore, the analysis revealed improvements in the homogeneity index (HI) and conformity index (CI) in mixed beam plans, ensuring a more uniform dose distribution and better conformity to the target volume. Despite the dosimetric advantages of mixed beam planning, challenges such as complex dose calculations, lack of standardized protocols, and limited clinical data on long-term outcomes remain areas of concern.
Moving forward, efforts should focus on refining dosimetry tools and algorithms to accurately model mixed beam interactions. Additionally, advancements in cost-effective technologies and standardized protocols can enhance the accessibility and efficacy of mixed beam planning, especially in resource-constrained settings. Incorporating adaptive planning, advanced imaging modalities, and patient-centered outcomes can further optimize treatment strategies and improve patient quality of life in cervical cancer management.
Key Takeaways:
– Mixed beam planning offers dosimetric advantages by optimizing tumor dose escalation and minimizing OAR exposure in cervical cancer treatment.
– Challenges such as complex dose calculations and limited clinical data on outcomes underscore the need for continued research and technological innovations in mixed beam planning.
– Standardized protocols, advanced imaging modalities, and patient-centered approaches are essential for enhancing the efficacy and accessibility of mixed beam planning in diverse healthcare settings.
Tags: clinical trials
Read more on scirp.org